Full-Time

Research Associate Lead

Services

Cellanome

Cellanome

51-200 employees

Automated platform for live single-cell assays

Compensation Overview

$88k - $106k/yr

+ Stock options

San Diego, CA, USA

In Person

Wednesday-through-Sunday or Thursday-through-Monday schedule.

Bachelor's

Category
Biology & Biotech (1)
Required Skills
Cell Biology

Get referred to Cellanome

See people who can refer or advise you

Requirements
  • A bachelor's degree in cell biology, molecular biology, or a related field is required.
  • A minimum of 5 years of experience working in a laboratory environment and hands-on experience with cell culture techniques and assays are required.
  • Demonstrated experience training, mentoring, or qualifying junior laboratory staff, or serving as a technical point of contact or shift lead, is required.
  • Strong attention to detail and the ability to follow protocols precisely are required.
  • Experience with lab automation and laboratory information management systems is required.
  • Excellent communication and teamwork skills, with the ability to collaborate effectively with colleagues and communicate clearly with internal stakeholders, are required.
  • The ability to perform the essential duties of the position with or without reasonable accommodations is required.
  • The ability to lift up to 20 pounds for approximately 15% of the typical working day is required.
  • The ability to grasp with both hands, pinch with the thumb and forefinger, turn with the hand or arm, and reach above shoulder height is required.
  • The ability to comply with personal protective equipment requirements is required.
Responsibilities
  • Execute high-quality end-to-end workflows on the Cellanome R3200 platform.
  • Process samples end to end by preparing and assessing cells, setting up and monitoring instrument runs, overseeing automated library preparation, and performing final library quality control.
  • Serve as the technical point of contact and day-to-day owner for assigned service contracts from sample receipt through library delivery.
  • Coordinate daily run scheduling across samples, instruments, and staff, and balance workflow across the shift.
  • Train, onboard, and qualify Research Associates on protocols and instrumentation.
  • Serve as the first escalation point for Research Associates on shift for technical and workflow questions and troubleshooting.
  • Follow standard operating procedures precisely and document all steps, observations, and deviations in the laboratory information management system in real time.
  • Support troubleshooting with the lab development and other internal teams.
  • Make and document real-time judgment calls on whether to continue, rerun, or hold a sample, and escalate appropriately.
  • Improve existing processes by providing feedback and ideas to the laboratory information management system and lab development teams.
  • Onboard and execute new processes transferred from the development team as the menu expands.
  • Follow laboratory safety protocols and maintain a clean and organized work environment.
Desired Qualifications
  • Hands-on experience with both next-generation sequencing library preparation and mammalian cell culture.
  • Prior experience in a commercial services, contract research organization, or otherwise deadline-driven laboratory environment with defined turnaround-time commitments.
  • Experience authoring or revising standard operating procedures and supporting assay technology transfer from development into routine operation.
  • Experience with Hamilton laboratory automation is preferred.

Cellanome provides an automated platform for live-cell phenotypic and functional assays that analyze single cells at scale. It runs high-throughput experiments that integrate with existing lab workflows, collecting multi-parameter data and allowing iterative testing under different conditions. The system emphasizes single-cell granularity, scalable data collection, and easy assay customization without major process changes. Its goal is to help life sciences, medical research, pharmaceutical, and biotech teams gain deeper cellular insights to accelerate discovery through a platform-as-a-service model.

Company Size

51-200

Company Stage

Series C

Total Funding

$276.9M

Headquarters

Foster City, California

Founded

2020

Get referred to Cellanome

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Cellanome updated its website August 2026, showing active product and content momentum.
  • AGBT March 2026 coverage and April 2026 posters show expanding scientific validation.
  • Psomagen added R3200 on March 26, 2026, expanding external distribution and credibility.

What critics are saying

  • The June 22, 2026 $75.9 million Form D signals continued capital dependence.
  • Psomagen's March 26, 2026 launch validates Cellanome while commoditizing its core workflow.
  • Any R3200 commercialization stumble kills a hardware-plus-consumables model before recurring revenue matures.

What makes Cellanome unique

  • R3200 pairs live-cell imaging with single-cell transcriptomics from the same cells.
  • CellCage technology keeps cells viable, trackable, and measurable over time.
  • Omead Ostadan’s December 2025 debut signaled a platform-first strategy across multi-omics biology.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Stock Options

401(k) Retirement Plan

Flexible Work Hours

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

57%

2 year growth

0%
U.S. Securities and Exchange Commission
Jul 17th, 2026
EDGAR Filing Documents for 0000905148-26-003005

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231Type: D | Act: 33 | File No.: 021-588010 | Film No.: 261104659

Intelligence360 News
Jul 17th, 2026
Cellanome files to raise $75.9M for live-cell imaging and single-cell transcriptomics platform

Cellanome has filed a notice with the US Securities and Exchange Commission to raise up to $75.9 million in new funding. The filing was made under Regulation D of the Securities Act of 1933, which allows companies to sell securities without full registration. The company develops technologies that combine longitudinal live-cell imaging with single-cell transcriptomics from the same cells. This approach enables scientists to capture cellular dynamics over time and connect cellular behaviour with molecular state. Researchers can access Cellanome's technology by implementing its R3200 platform in their laboratories, using its assay services, or collaborating with the company's scientists on new applications.

The Business Journals
Jan 30th, 2024
Peninsula startup with Illumina roots lands $150 million to peer deeper into cells

A Peninsula startup launched by top former Illumina execs raises $150 million to help researchers see what happens when cells dance with each other.

The Business Journals
Dec 8th, 2021
Former Illumina execs, Grail co-founder raise $21M for biotech startup

Biotech A-listers have come together to launch a new venture. What's it targeting? They're not saying.